Get the app
public
ios_share
The Long Run with Luke Timmerman
chevron_right
Ep134: Emile Nuwaysir on In Vivo Gene Editing Therapies
Apr 24, 2023
01:16:22
forum
Ask episode
play_arrow
Play
view_agenda
Chapters
auto_awesome
Transcript
info_circle
Episode notes
Emile Nuwaysir, CEO of Boston-based Ensoma, on developing off-the-shelf in vivo gene editing therapies.